The Immunoassay Microplate Reader market is segmented by application, with Clinical Diagnostics and Research & Development as key subcategories. Clinical Diagnostics dominates due to its critical role in disease screening, such as infectious diseases and autoimmune disorders, requiring high-throughput platforms for accuracy and speed. Hospitals, diagnostic labs, and point-of-care settings drive demand, accounting for ~60% of the market. Conversely, Research & Development applicationsโprimarily in academic, pharmaceutical, and biotechnology sectorsโfavor flexibility for assay optimization and biomarker discovery. This segment contributes ~40% of the market, with growth fueled by advancements in personalized medicine and drug development. Immunoassay Microplate Reader segmentation by application reveals distinct adoption patterns, reflecting unmet needs in clinical scalability versus research innovation.